Hematology Diagnostics Market - Forecast(2022 - 2027)

Report Code: HCR 57154 Report Format: PDF + Excel

Hematology Diagnostics Market Overview

Hematology Diagnostics Market size is projected to reach $9,390 million by 2026, growing at a CAGR of 5.8% over 2021-2026. Hematology is a part of drug that controls the study of blood, blood illnesses and blood-forming organs. Bleeding disorders such as hemophila and blood clots, and blood cancer are some types of blood conditions that needs hematology treatment. It deals with the problems related with white blood cells, red blood cells, bone marrow, lymph, and platelets. 

Diagnostics such as flow cytometers are used for evaluating hematologic disease and monitoring HIV infection and also assessing peripheral blood and bone marrow. A hematocrit test helps to diagnose blood disorders such as anemia. Immunohistology diagnostics is a process in order to remove cancer tissue during biopsy. Increasing prevalence of blood disorders and growing technological advancement is the major factor driving the growth of this market. Furthermore, increasing research and development activities in medical industry and increasing awareness about health is set to further enhance the overall market demand for Hematology Diagnostics Market for the period 2021-2026. 

Hematology Diagnostics Market  Report Coverage

The report: “Hematology Diagnostics Market Forecast (2021-2026)”, by IndustryARC, covers an in-depth analysis of the following segments of the Hematology Diagnostics Market.    
By Product: Instrument, and Consumables
By Test Type: Blood Count, Platelet Function, Hemoglobin, and Hematocrit
By End-Use Industry: Hospitals, Diagnostics Center, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (U.K, Germany, Italy, France, Spain, Russia, Rest of Europe), Asia Pacific (China, Australia, Japan, South Korea, India, Rest of Asia Pacific), South America (Brazil, Argentina, Others) and Rest of the World (Middle East, Africa)

Key Takeaways

  • Geographically, in 2020, North America dominated the Hematology Diagnostics Market owing to increasing advanced technologies for the POC test, increasing geriatric population, and favorable reimbursement scenario.
  • Detailed analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Hematology Diagnostics Market report.   
  • High cost associated with diagnostics is set to create hurdles for the Hematology Diagnostics Market.   

Hematology Diagnostics Market Size, By End-Use Industry 2020-2026 (USD Million)

    
For More Details on This Report - Request for Sample

Hematology Diagnostics Segment Analysis – By Product

The global Hematology Diagnostics Market based on Product can be further segmented into Instrument, and Consumables. The Instrument segment held the major share in 2020. This is mainly owing to increasing technological advancement and rising automation. Moreover, advanced instruments offer good sensitivity, reliability, specificity, ease of operation, and safety that increases the growth of this market. The Consumables segment is estimated to register the fastest CAGR of 1.4% for the period 2021-2026. This is mainly owing to increase in diagnosis of blood disorder with flow cytometers that increasing the growth of this segment.

Hematology Diagnostics Segment Analysis – By End-Use Industry

The global Hematology Diagnostics Market based on End-Use Industry can be further segmented into Hospitals, Diagnostics Center, and Others. The Hospital segment registers for the highest Hematology Diagnostics market share in 2020. This is owing to hospitals offer point of care hematology tests at an affordable price and increasing skilled professional in hospital. Furthermore, the market is expected to expand as the number of hospitals conducting haemoglobin tests with critical safety requirements increases. The Diagnostics Center segment is estimated to register the fastest CAGR of 1.5% over 2021-2026. This is mainly owing to rising research and development and increasing number of diagnostic centers having Immunohistology diagnostics, increasing automation of diagnostic instruments and availability of advanced instruments and are increasing the growth of this market.

Hematology Diagnostics Segment Analysis – By Geography

North America dominated the Hematology Diagnostics Market with major share of 40% in 2020. This is owing to increasing advanced technologies for the POC test, increasing geriatric population, and favorable reimbursement scenario. According to the Centers for Disease Control and Prevention in 2017, approximately 70,000 to 100,000 Americans are suffering from a genetic blood disorder that increases the demand of diagnosis and are rising the growth of this market. However, Asia Pacific is estimated to be the fastest growing with a CAGR of 2.9% during the forecast period 2021-2026 owing to rising population and increasing development in healthcare.

Hematology Diagnostics Market Drivers

Increasing Prevalence of Blood Disorders 

Increasing prevalence of blood disorders, and changing in lifestyle are increasing the growth of the Hematology Diagnostics Market. According to Center for Disease Control and Prevention (CDC), about 1 million people in U.S. are suffering have hemophilia that increases hematocrit test and this is leading to the rise of the Hematology Diagnostics Market over 2021-2026.   

Growing Technological Advancement

Technological advancements in the field of diagnostics, improvement in the research increases the growth of this Market too. Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology that increases the innovation in technology and are increasing the growth of Hematology Diagnostics Market over 2021-2026.  

Hematology Diagnostics Market Challenges

High Cost Associated with Diagnostics

The factors that is set to impede the growth of the Hematology Diagnostics Market are the high cost of technologies used for diagnosis. Moreover, lack of skilled professional in various healthcare sector is set to create hurdles for the Hematology Diagnostics Market.  

Covid-19 Impact: 

COVID-19 pandemic had greatly affected the Hematology Diagnostics Market. During pandemic, healthcare sector are involved in recovering coronavirus cases. In hospitals, doctors are busy in coronavirus ward that decreases the use of diagnostics and are negatively impacted the growth of this market. 

Hematology Diagnostics Landscape

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Hematology Diagnostics Market. Hematology Diagnostics top 10 companies include, Abbott, Beckman Coulter, Bio-Rad Laboratories, Danaher, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Horiba, Mindray, Siemens Healthcare, CellaVision and Sysmex Corporation.

Development

In April 2019, Danaher (Beckman Coulter, Inc.) received CE Mark of its DxH 520 hematology analyzer, which is designed to help physician office laboratories.

Relevant Reports:

Report Code: HCR 0021

Healthcare Equipment Market

Report Code: HCR 0176

For more Lifesciences and Healthcare Market reports, please click here
1. Hematology Diagnostics Market Overview
    1.1 Definitions and Scope
2. Hematology Diagnostics Market Executive Summary
    2.1 Market Size and Key Trends
    2.2 Key trends by Product
    2.3 Key trends by Test Type
    2.4 Key trends by End-Use Industry
    2.5 Key trends by Geography
3. Hematology Diagnostics Market Landscape
    3.1 Market Share Analysis- Key Companies
    3.2 Product Benchmarking- Key Companies
    3.3 Financial Analysis - Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis
4. Hematology Diagnostics Market- Startup companies Scenario Premium Premium
    4.1 Key startup company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Application Analysis
        4.1.4 Venture Capital and Funding Scenario
5. Hematology Diagnostics Market- Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of successful ventures
6. Hematology Diagnostics Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining Power of Suppliers
        6.3.2 Bargaining Powers of Customers
        6.3.3 Threat of New Entrants
        6.3.4 Rivalry Among Existing Players
        6.3.5 Threat of Substitutes
7. Hematology Diagnostics Market Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Hematology Diagnostics Market– By Product (Market Size -$Million/$Billion)
    8.1 Instrument
    8.2 Consumables
9. Hematology Diagnostics Market– By Test Type (Market Size -$Million/$Billion)
    9.1 Blood Count
    9.2 Platelet Function
    9.3 Hemoglobin
    9.4 Hematocrit
10. Hematology Diagnostics Market– By End-Use Industry (Market Size -$Million/$Billion)
    10.1 Hospitals
    10.2 Diagnostics Center
    10.3 Others
11. Hematology Diagnostics Market- By Geography (Market Size -$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 Italy
        11.2.4 France
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Australia
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 India
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Others
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Hematology Diagnostics Market Entropy
13. Hematology Diagnostics Market- Industry / Segment Competition landscape Premium Premium
    13.1 Market Share Analysis
        13.1.1 Market Share by Country- Key companies
        13.1.2 Market Share by Region- Key companies
        13.1.3 Market Share at Global Level- Key companies
        13.1.4 Best Practices for Companies
14. Hematology Diagnostics Market- Key Company List by Country Premium Premium
15. Hematology Diagnostics Market Company Analysis
    15.1 Company Revenue, Products, M&A, Developments
    15.2 Company 1
    15.3 Company 2
    15.4 Company 3
    15.5 Company 4
    15.6 Company 5
    15.7 Company 6
    15.8 Company 7
    15.9 Company 8
    15.10 Company 9
    15.11 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Competitive Landscape Market 2019-2024 ($M)
2.Global Competitive Landscape Market 2019-2024 (Volume/Units)
3.North America Competitive Landscape Market 2019-2024 ($M)
4.South America Competitive Landscape Market 2019-2024 ($M)
5.Europe Competitive Landscape Market 2019-2024 ($M)
6.APAC Competitive Landscape Market 2019-2024 ($M)
7.MENA Competitive Landscape Market 2019-2024 ($M)

LIST OF FIGURES

1.US Hematology Diagnostics Market Revenue, 2019-2024 ($M)
2.Canada Hematology Diagnostics Market Revenue, 2019-2024 ($M)
3.Mexico Hematology Diagnostics Market Revenue, 2019-2024 ($M)
4.Brazil Hematology Diagnostics Market Revenue, 2019-2024 ($M)
5.Argentina Hematology Diagnostics Market Revenue, 2019-2024 ($M)
6.Peru Hematology Diagnostics Market Revenue, 2019-2024 ($M)
7.Colombia Hematology Diagnostics Market Revenue, 2019-2024 ($M)
8.Chile Hematology Diagnostics Market Revenue, 2019-2024 ($M)
9.Rest of South America Hematology Diagnostics Market Revenue, 2019-2024 ($M)
10.UK Hematology Diagnostics Market Revenue, 2019-2024 ($M)
11.Germany Hematology Diagnostics Market Revenue, 2019-2024 ($M)
12.France Hematology Diagnostics Market Revenue, 2019-2024 ($M)
13.Italy Hematology Diagnostics Market Revenue, 2019-2024 ($M)
14.Spain Hematology Diagnostics Market Revenue, 2019-2024 ($M)
15.Rest of Europe Hematology Diagnostics Market Revenue, 2019-2024 ($M)
16.China Hematology Diagnostics Market Revenue, 2019-2024 ($M)
17.India Hematology Diagnostics Market Revenue, 2019-2024 ($M)
18.Japan Hematology Diagnostics Market Revenue, 2019-2024 ($M)
19.South Korea Hematology Diagnostics Market Revenue, 2019-2024 ($M)
20.South Africa Hematology Diagnostics Market Revenue, 2019-2024 ($M)
21.North America Hematology Diagnostics By Application
22.South America Hematology Diagnostics By Application
23.Europe Hematology Diagnostics By Application
24.APAC Hematology Diagnostics By Application
25.MENA Hematology Diagnostics By Application